G4/HDAC-IN-1 is a dual-targeting G4/HDAC inhibitor that suppresses intracellular HDAC activity (IC50 = 1.1 μM) and induces G-quadruplex (G4) formation; it inhibits the proliferation of triple-negative breast cancer cells and suppresses tumor growth in xenograft models, demonstrating its potential for cancer research.